Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pepijn Al

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Bioethics|October 20, 2020
The value of communities and their consent: A communitarian justification of community consent in medical researchPepijn Al
Journal of Medical Ethics|December 24, 2024
Is framing of treatment options misleading? Maybe, but not because of a lower-bound readingPepijn Al
Trials|October 6, 2023
Response to MerzPepijn Al, Jamie Brehaut, Charles Weijer
Medicine, Health Care, and Philosophy|January 3, 2026
The ethical permissibility of financial incentivesPepijn Al, Jamie Brehaut, Katie Gillies, et al.
Trials|March 27, 2023
Changing patient preferences toward better trial recruitment: an ethical analysisPepijn Al, Spencer Hey, Charles Weijer, et al.
Biologicals : Journal of the International Association of Biological Standardization|June 22, 2026
Refining the regulatory and ethics context of controlled human infection models - a stakeholder meeting reportVictor Cnossen, Annefleur Hensen, Laura Pattacini, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Bioethics|October 20, 2020
The value of communities and their consent: A communitarian justification of community consent in medical researchPepijn Al
Journal of Medical Ethics|December 24, 2024
Is framing of treatment options misleading? Maybe, but not because of a lower-bound readingPepijn Al
Trials|October 6, 2023
Response to MerzPepijn Al, Jamie Brehaut, Charles Weijer
Medicine, Health Care, and Philosophy|January 3, 2026
The ethical permissibility of financial incentivesPepijn Al, Jamie Brehaut, Katie Gillies, et al.
Trials|March 27, 2023
Changing patient preferences toward better trial recruitment: an ethical analysisPepijn Al, Spencer Hey, Charles Weijer, et al.
Biologicals : Journal of the International Association of Biological Standardization|June 22, 2026
Refining the regulatory and ethics context of controlled human infection models - a stakeholder meeting reportVictor Cnossen, Annefleur Hensen, Laura Pattacini, et al.
Pageof 1